Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids

Chemical Research in Toxicology

Volumn 24, Issue 1, 2011, Pages 111-118

  Choi, Jaewoo ^a   Zhang, Wujuan ^a   Gu, Xiaodong ^a   Chen, Xi ^a   Hong, Li ^a   Laird, James M ^a   Salomon, Robert G ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 PALMITYL 2 (4 HYDROXY 7 OXO 5 HEPTENOYL) SN GLYCERO 3 PHOSPHOCHOLINE; 2,4 DINITROPHENYLHYDRAZINE; LACTONE DERIVATIVE; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED PHOSPHATIDYLCHOLINE; OXIDIZED PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; UNCLASSIFIED DRUG;

ARTICLE; DEACYLATION; OXIDATION; PH; TEMPERATURE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LIPOPROTEINS, LDL; LYSOPHOSPHATIDYLCHOLINES; MASS SPECTROMETRY; OXIDATION-REDUCTION; PHOSPHATIDYLCHOLINES; TEMPERATURE;

EID: 78651496514     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100305b     Document Type: Article

References (37)

1. Chen, X., Zhang, W., Laird, J., Hazen, S. L., and Salomon, R. G. (2008) Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids J. Lipid Res. 49, 832-846
2. Zhang, R., Rodrigues, B., and MacLeod, K. M. (2006) Lysophosphatidylcholine potentiates phenylephrine responses in rat mesenteric arterial bed through modulation of thromboxane A2 J. Pharmacol. Exp. Ther. 317, 355-361
3. Shi, A., Yoshinari, M., Iino, K., Wakisaka, M., Iwase, M., and Fujishima, M. (1999) Lysophosphatidylcholine molecular species in low density lipoprotein and high density lipoprotein in alloxan-induced diabetic rats: effect of probucol Exp. Clin. Endocrinol. Diabetes 107, 337-342
4. Shi, A. H., Yoshinari, M., Wakisaka, M., Iwase, M., and Fujishima, M. (1999) Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes Horm. Metab. Res. 31, 283-286
5. Sasagawa, T., Suzuki, K., Shiota, T., Kondo, T., and Okita, M. (1998) The significance of plasma lysophospholipids in patients with renal failure on hemodialysis J. Nutr. Sci. Vitaminol. (Tokyo) 44, 809-818
6. 31P NMR and MALDI-TOF MS Clin. Biochem. 38, 925-933
7. Mehta, D., Gupta, S., Gaur, S. N., Gangal, S. V., and Agrawal, K. P. (1990) Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine Am. Rev. Respir. Dis. 142, 157-161
8. Yan, J. J., Jung, J. S., Lee, J. E., Lee, J., Huh, S. O., Kim, H. S., Jung, K. C., Cho, J. Y., Nam, J. S., Suh, H. W., Kim, Y. H., and Song, D. K. (2004) Therapeutic effects of lysophosphatidylcholine in experimental sepsis Nat. Med. 10, 161-167
9. Zhang, B., Fan, P., Shimoji, E., Itabe, H., Miura, S., Uehara, Y., Matsunaga, A., and Saku, K. (2006) Modulating effects of cholesterol feeding and simvastatin treatment on platelet-activating factor acetylhydrolase activity and lysophosphatidylcholine concentration Atherosclerosis 186, 291-301
10. Murphy, A. A., Santanam, N., Morales, A. J., and Parthasarathy, S. (1998) Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis J. Clin. Endocrinol. Metab. 83, 2110-2113
11. Ryborg, A. K., Gron, B., and Kragballe, K. (1995) Increased lysophosphatidylcholine content in lesional psoriatic skin Br. J. Dermatol. 133, 398-402
12. Steinbrecher, U. P., Zhang, H. F., and Lougheed, M. (1990) Role of oxidatively modified LDL in atherosclerosis Free Radical Biol. Med. 9, 155-168
13. Sakai, M., Miyazaki, A., Hakamata, H., Sasaki, T., Yui, S., Yamazaki, M., Shichiri, M., and Horiuchi, S. (1994) Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages J. Biol. Chem. 269, 31430-31435
14. Parthasarathy, S. and Barnett, J. (1990) Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100 Proc. Natl. Acad. Sci. U.S.A. 87, 9741-9745
15. Tew, D. G., Southan, C., Rice, S. Q., Lawrence, M. P., Li, H., Boyd, H. F., Moores, K., Gloger, I. S., and Macphee, C. H. (1996) Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins Arterioscler., Thromb., Vasc., Biol. 16, 591-599
16. Lynch, S. M. and Frei, B. (1993) Mechanisms of copper-and iron-dependent oxidative modification of human low density lipoprotein J. Lipid Res. 34, 1745-1753
17. Ali, S., Davis, M. G., Becker, M. W., and Dorn, G. W. (1993) Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor J. Biol. Chem. 268, 17397-17403
18. Cathcart, M. K., McNally, A. K., and Chisolm, G. M. (1991) Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex J. Lipid Res. 32, 63-70
19. Negre-Salvayre, A., Lopez, M., Levade, T., Pieraggi, M. T., Dousset, N., Douste-Blazy, L., and Salvayre, R. (1990) Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines Biochim. Biophys. Acta 1045, 224-232 (Pubitemid 20249365)
20. Gu, X., Sun, M., Gugiu, B., Hazen, S., Crabb, J. W., and Salomon, R. G. (2003) Oxidatively truncated docosahexaenoate phospholipids: total synthesis, generation, and peptide adduction chemistry J. Org. Chem. 68, 3749-3761
21. Sun, M., Finnemann, S. C., Febbraio, M., Shan, L., Annangudi, S. P., Podrez, E. A., Hoppe, G., Darrow, R., Organisciak, D. T., Salomon, R. G., Silverstein, R. L., and Hazen, S. L. (2006) Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions J. Biol. Chem. 281, 4222-4230
22. Deng, Y. and Salomon, R. G. (1998) Total synthesis of ©-hydroxy-α,β-unsaturated aldehydic esters of cholesterol and 2-lysophosphatidylcholine J. Org. Chem. 63, 7789-7794
23. Gallasch, B. A. and Spiteller, G. (2000) Synthesis of 9,12-dioxo-10(Z)-dodecenoic acid, a new fatty acid metabolite derived from 9-hydroperoxy-10,12-octadecadienoic acid in lentil seed (Lens culinaris Medik.) Lipids 35, 953-960
24. Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Febbraio, M., Hajjar, D. P., Silverstein, R. L., Hoff, H. F., Salomon, R. G., and Hazen, S. L. (2002) A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions J. Biol. Chem. 277, 38517-38523
25. Sun, M., Deng, Y., Batyreva, E., Sha, W., and Salomon, R. G. (2002) Novel bioactive phospholipids: practical total syntheses of products from the oxidation of arachidonic and linoleic esters of 2-lysophosphatidylcholine(1) J. Org. Chem. 67, 3575-3584
26. 2+ catalyzes vitamin E-induced fragmentation of hydroperoxy and hydroxy endoperoxides that generates gamma-hydroxy alkenals J. Am. Chem. Soc. 129, 6088-6089
27. Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B., Fox, P. L., Hoff, H. F., Salomon, R. G., and Hazen, S. L. (2002) Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36 J. Biol. Chem. 277, 38503-38516
28. Bligh, E. G. and Dyer, W. J. (1959) A rapid method of total lipid extraction and purification Can. J. Biochem. Physiol. 37, 911-917
29. Subbanagounder, G., Deng, Y., Borromeo, C., Dooley, A. N., Berliner, J. A., and Salomon, R. G. (2002) Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells Vasc. Pharmacol. 38, 201-209
30. Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., Chen, J., Zhang, R., Silverstein, R. L., and Hazen, S. L. (2007) Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype Nat. Med. 13, 1086-1095
31. Hollyfield, J. G., Bonilha, V. L., Rayborn, M. E., Yang, X., Shadrach, K. G., Lu, L., Ufret, R. L., Salomon, R. G., and Perez, V. L. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration Nat. Med. 14, 194-198
32. Hollyfield, J. G., Perez, V. L., and Salomon, R. G. (2010) A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration Mol. Neurobiol. 41, 290-298
33. West, X. Z., Malinin, N. L., Merkulova, A. A., Tischenko, M., Kerr, B. A., Borden, E. C., Podrez, E. A., Salomon, R. G., and Byzova, T. V. (2010) Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 467, 972 -976.
34. Kaur, K., Salomon, R. G., O'Neil, J., and Hoff, H. F. (1997) (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins Chem. Res. Toxicol. 10, 1387-1396
35. Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., and Roberts, L. J., 2nd. (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. U.S.A. 87, 9383-9387
36. Mohler, E. R., Ballantyne, C. M., Davidson, M. H., Hanefeld, M., Ruilope, L. M., Johnson, J. L., and Zalewski, A. (2008) The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study J. Am. Coll. Cardiol. 51, 1632-1641
37. Rosenson, R. S. (2009) Future role for selective phospholipase A2 inhibitors in the prevention of atherosclerotic cardiovascular disease Cardiovasc. Drugs Ther. 23, 93-101